Last reviewed · How we verify

NCT05516810

The Accuracy of Ultrasound Diagnosis of Hydatidiform Moles

Active, enrolled Last updated 11 June 2024
What this trial tests

trial in Hydatidiform Mole (Diagnosis) in 500 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline
19 October 2021
Primary endpoint
5 May 2024
30 September 2024

Quick facts

Lead sponsorKing's College Hospital NHS Trust
StatusActive, enrolled
Study typeOBSERVATIONAL
Enrollment500
Start date19 October 2021
Primary completion5 May 2024
Estimated completion30 September 2024
Sites2 locations across United Kingdom

Conditions studied

Sponsor

King's College Hospital NHS Trust

Who can join

16 and older, female only, with Hydatidiform Mole (Diagnosis) or Abortion, Spontaneous. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a prospective observational study assessing which ultrasound findings are best at excluding a molar pregnancy in first trimester miscarriage.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other King's College Hospital NHS Trust trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05516810.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing